Photo credit: UC Regents The California Institute for Regenerative Medicine (CIRM) is investing $4 million to support Dr. William Murphy and UC Davis researchers to develop and test a chimeric antigen receptor (CAR) T-cell therapy to treat various B-cell malignancies, ranging from lymphomas to leukemias. In this Q&A—courtesy of UC Davis Health—Dr. Murphy discusses the importance of T-cell therapy and its implications … Continue reading Investing in CAR T-cell therapy to treat cancer
UC Davis Health
UC Davis Health researchers aim to use CAR T cells for HIV cure
Dr. Abedi (right) in the lab at UC Davis Health. He and his team of researchers have launched a study looking to identify a potential cure for HIV. Photo Courtesy of UC Davis Health. Worldwide, almost 38 million people are living with HIV—the virus that can lead to AIDS— and it’s estimated that 75% of … Continue reading UC Davis Health researchers aim to use CAR T cells for HIV cure
Stem cell byproducts provide insight into cure for spina bifida
A diagram of an infant born with spina bifida, a birth defect where there is an incomplete closing of the backbone portion of the spinal cord. Photo courtesy of the Texas Children's Hospital website. Some of you might remember a movie in the early 2000s by the name of "Miracle in Lane 2". The film … Continue reading Stem cell byproducts provide insight into cure for spina bifida
The Stem Cellar 